FDA Approves Triple Fixed-dose Inhaled Therapy for COPD
July 24, 2020

Approval was awarded to AstraZeneca for an inhaled, fixed-dose combination of budesonide/glycopyrrolate/formoterol fumarate.

Asthma, COPD Inhaler Adherence Up During Pandemic
May 13, 2020

Adherence to controller medication appears to have increased between early January and late March among patients with asthma and COPD, finds a new study.

12 Drugs Approved for Primary Care in 2019
December 12, 2019

ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.